![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_7bc7b7c24728705cf934876c78def295.svg) | (4R)-4-Methyl-6-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one | IC50 | 7700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_865fc9ed2e0df35ce8eeb60888434d91.svg) | Nvs-cecr2-1 | IC50 | 47.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_7672efe17e797eb419ee4a28137dfb48.svg) | 4-Cyano-N-(1,3-diethyl-2-oxoquinolin-6-yl)benzenesulfonamide | IC50 | 20000.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_cc13628645c821a4d949b6b2e0576a37.svg) | 4-[(2s,4r)-1-Acetyl-4-[(4-Chlorophenyl)amino]-2-Methyl-1,2,3,4-Tetrahydroquinolin-6-Yl]benzoic Acid | IC50 | 31622.78 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_655ca0b7debd175337b550410e8c6b74.svg) | 3-[7-(Difluoromethyl)-6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-N-methyl-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxamide | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_72013193af36cf2fbb8c74b5e81239a2.svg) | N,2-Dimethyl-5-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)benzenesulfonamide | IC50 | 3162.28 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_ba6c458cef44ebde344a4c0e58953eb6.svg) | N-[3-(3-Methyl-4-Oxo-4,5,6,7-Tetrahydro-2h-Isoindol-1-Yl)-4-Phenoxyphenyl]methanesulfonamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_051f9e709e22ad5d314115e85d5d3f31.svg) | N-[5-(3-Methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-2-morpholin-4-ylphenyl]methanesulfonamide | IC50 | 158.49 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_88d123e25c79c23e380ea61e9c6d6f3a.svg) | 1-(3-Phenylazanyl-1,4,6,7-Tetrahydropyrazolo[4,3-C]pyridin-5-Yl)ethanone | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_21791211a0ff9f7199dbc4e5c7fe1e09.svg) | (4R)-6-[7-(Difluoromethyl)-6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-4-methyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_a57c49522efad3c19fd54528b073b252.svg) | N,6-Dimethyl-7-oxo-N-[1-(1-phenylethyl)piperidin-4-yl]-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 330.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_add537e7ba57f80f986ad07ba53c267a.svg) | N-Methyl-7-oxo-6-prop-2-enyl-N-[1-(6-pyrazol-1-ylpyrimidin-4-yl)piperidin-4-yl]-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 59.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_dcc61464f1809f76f17cea036c0775c8.svg) | N-[1-(6-Methoxypyrimidin-4-yl)piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 130.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_d83845587db0df9332f6f376e46aa377.svg) | N-Methyl-7-oxo-6-prop-2-enyl-N-(1-pyrimidin-4-ylpiperidin-4-yl)-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 240.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_f19a9c9707c46df0879b9f2812559e65.svg) | 6-Methyl-N-(1-methylpiperidin-4-yl)-7-oxo-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 1100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_e6435e1c1ace8c1bb76f646e1e7e5be4.svg) | N,6-Dimethyl-7-oxo-N-(1-propan-2-ylpiperidin-4-yl)-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_c6b1bdea8f3e50675b103182dfa1ee5e.svg) | N,6-Dimethyl-N-(1-methylpiperidin-4-yl)-7-oxo-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 780.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_0a74123196ab80d38d741ca50ae10cfb.svg) | N-Methyl-7-oxo-6-prop-2-enyl-N-[1-[6-(trifluoromethyl)pyrimidin-4-yl]piperidin-4-yl]-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_7bae080063e1125ada0207d815a479a7.svg) | 1-[3-[7-(Difluoromethyl)-6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone | IC50 | 14000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_07f19120049570c4c459cbb4a2216ebe.svg) | 1-[3-[2-Fluoro-4-(1-methylpyrazol-4-yl)anilino]-1-[(3R)-oxolan-3-yl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_fb3bc1b253fbaa7f1b56c29c94ca8d3a.svg) | 8-[[(3R,4R)-3-[(1,1-Dioxothian-4-yl)methoxy]-1-methylpiperidin-4-yl]amino]-3-methyl-5-(5-methylpyridin-3-yl)-1H-1,7-naphthyridin-2-one | Ki | 794.33 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_b413d5392173090cf53bb11aaf46bdbd.svg) | N,2-Dimethyl-7-oxo-N-[1-[(1S)-1-phenylethyl]piperidin-4-yl]-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 190.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_42c7f52a7c37a5dfea55883fec456ae7.svg) | N-[1-(2,6-Dimethylpyrimidin-4-yl)piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 93.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_b487bb22073af6353aebf0bea2bfe1f3.svg) | N-[1-[6-(3-Methoxyphenyl)pyrimidin-4-yl]piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_a21c81ae354026cffe515a2d67974e91.svg) | N-[1-(6-Tert-butylpyrimidin-4-yl)piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 55.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_6c4432448e4c0125d40d74a3410f642c.svg) | N-Methyl-7-oxo-N-[1-(1-phenylethyl)piperidin-4-yl]-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_3c459c48f202f578dc9f8f1ebc040a92.svg) | N-[1-(6-Cyclopropyl-2-methylpyrimidin-4-yl)piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 52.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_6ed162bb06cd267cfad3e6dbde68556f.svg) | N-[1-(6-Methoxy-2-methylpyrimidin-4-yl)piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 71.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_4c12eb32b9fbf8ca0bcddd698233a484.svg) | N-[1-[6-(2-Methoxyphenyl)pyrimidin-4-yl]piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 45.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_85a4180641e3b44b6bd526aca7d693f0.svg) | N-[1-[6-(2-Fluorophenyl)pyrimidin-4-yl]piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 44.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_4addc440be7b4f4f1dd431f33beb24d5.svg) | N,2-Dimethyl-7-oxo-N-[1-[(1R)-1-phenylethyl]piperidin-4-yl]-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_d262dcaff74844807c790f07398e5bec.svg) | N-[1-[6-(Furan-2-yl)pyrimidin-4-yl]piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 45.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_a775ab6d00d7ea66feb4cf3a12de81bd.svg) | N-[1-(6-Cyclopropylpyrimidin-4-yl)piperidin-4-yl]-N-methyl-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 83.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_28cc43a8c9edaa43ff31e039dd127874.svg) | N-Methyl-N-[1-[6-(2-methylphenyl)pyrimidin-4-yl]piperidin-4-yl]-7-oxo-6-prop-2-enyl-1H-pyrrolo[2,3-c]pyridine-4-carboxamide | IC50 | 46.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_9d2256befb487ba98b8f539225685dcb.svg) | N,N,2-Trimethyl-5-(3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)benzenesulfonamide | IC50 | 251.19 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_7ad22cf31a99e547f3d6f423a77b40a4.svg) | N-[2-Methyl-5-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)phenyl]methanesulfonamide | IC50 | 501.19 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_b9456135d3548ae476ba7b50ec0687e7.svg) | N-[2-Methyl-5-(3-methyl[1,2,4]triazolo[3,4-a]phthalazin-6-yl)phenyl]propanamide | IC50 | 5011.87 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_7f92ca0416f167a45137643b530c6f45.svg) | 2-Chloro-N-[5-(3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-2-morpholin-4-ylphenyl]benzenesulfonamide | IC50 | 25118.86 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_1e0871e94bf847647ed20c44f62b70ad.svg) | 4-Methoxy-N-[2-(4-methylpiperazin-1-yl)-5-(3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)phenyl]benzenesulfonamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_830ac9fb9205e89525afaae7be3a9800.svg) | 4-Chloro-N-[5-(3-methyl-[1,2,4]triazolo[3,4-a]phthalazin-6-yl)-2-morpholin-4-ylphenyl]benzenesulfonamide | IC50 | 19952.62 [1] |
![](https://images.aatbio.com/dataset/ic50/cat-eye-syndrome-critical-region-protein-2_dc562a7b4f1d2c7d72c7eea3aa94fcab.svg) | 3-[2-(2,4-Difluorophenoxy)-5-methylsulfonylphenyl]-1-methyl-6H-pyrrolo[2,3-c]pyridin-7-one | IC50 | 1000.0 [1] |